In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Tarun Vemulkar, CTO and Co-Founder of Semarion, to explore how their groundbreaking SemaCyte® platform is reshaping the way scientists handle, study, and analyze cells. They dive into the intersection of materials science and cell biology, unpacking how Semarion’s smart materials enable faster, more reproducible cell-based assays — ultimately accelerating the path from discovery to therapy.

What You’ll Hear:

• The Origins of Semarion – how the team spun out to solve long-standing challenges in cell handling.
• The SemaCyte® Platform Explained – how controllable microcarriers enable miniaturized, high-precision cell assays.
• Bridging Materials Science and Biology – how Semarion’s interdisciplinary approach is unlocking new efficiencies in drug discovery workflows.
• Real-World Applications – use cases for pharma, biotech, and academia in streamlining screening and model validation.
• Looking Ahead – where Semarion sees the future of smart materials and how they’re scaling their impact across the life sciences ecosystem.

🌐 Explore & Connect

Learn more about Semarion and the SemaCyte® platform on their website or LinkedIn. 

Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Links

• Science in Real Time: https://www.aracelibio.com/science-irt-podcast-biology-big-data/
• Araceli Biosciences LinkedIn: https://www.linkedin.com/company/araceli-biosciences/
• Semarion Website: http://www.semarion.com/ 
• Semarion LinkedIn: https://uk.linkedin.com/company/semarion